Elanco Animal Health Inc financial data

Symbol
ELAN on NYSE
Industry
Pharmaceutical Preparations
Location
2500 Innovation Way, Greenfield, Indiana
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 292 % +37%
Quick Ratio 134 % +44.3%
Debt-to-equity 127 % +9.18%
Return On Equity -20.2 % -5447%
Return On Assets -8.9 % -5188%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 494M shares +0.33%
Common Stock, Shares, Outstanding 494M shares +0.33%
Entity Public Float 4.9B USD -47.3%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 493M shares +0.43%
Weighted Average Number of Shares Outstanding, Diluted 496M shares +0.65%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 4.37B USD -1.73%
Research and Development Expense 333M USD +3.74%
Costs and Expenses 5.66B USD +26.2%
Nonoperating Income (Expense) -75M USD -134%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.29B USD -3210%
Income Tax Expense (Benefit) 11M USD -500%
Net Income (Loss) Attributable to Parent -1.3B USD -4908%
Earnings Per Share, Basic -2.65 USD/shares -5200%
Earnings Per Share, Diluted -2.65 USD/shares -5200%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 345M USD +8.49%
Accounts Receivable, after Allowance for Credit Loss, Current 988M USD -5.99%
Inventory, Net 1.64B USD +2.63%
Assets, Current 4.05B USD +14.1%
Property, Plant and Equipment, Net 949M USD -5.1%
Operating Lease, Right-of-Use Asset 140M USD -0.71%
Intangible Assets, Net (Excluding Goodwill) 4.2B USD -12.4%
Goodwill 4.48B USD -26.1%
Other Assets, Noncurrent 346M USD -6.23%
Assets 14B USD -11.1%
Accounts Payable, Current 302M USD -20.7%
Employee-related Liabilities, Current 157M USD +7.53%
Contract with Customer, Liability, Current 318M USD -3.34%
Liabilities, Current 1.23B USD -21.9%
Deferred Income Tax Liabilities, Net 530M USD -20.1%
Operating Lease, Liability, Noncurrent 110M USD -0.9%
Other Liabilities, Noncurrent 474M USD +93.5%
Liabilities 7.96B USD -3.93%
Accumulated Other Comprehensive Income (Loss), Net of Tax -465M USD -50%
Retained Earnings (Accumulated Deficit) -2.26B USD -136%
Stockholders' Equity Attributable to Parent 6.06B USD -19%
Liabilities and Equity 14B USD -11.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2M USD
Net Cash Provided by (Used in) Financing Activities -27M USD -116%
Net Cash Provided by (Used in) Investing Activities 37M USD
Common Stock, Shares Authorized 5B shares 0%
Common Stock, Shares, Issued 494M shares +0.33%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7M USD +74.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 345M USD +8.49%
Interest Paid, Excluding Capitalized Interest, Operating Activities 379M USD +42.5%
Deferred Tax Assets, Valuation Allowance 363M USD +59.2%
Deferred Tax Assets, Gross 815M USD +13.2%
Operating Lease, Liability 142M USD 0%
Depreciation 92M USD +3.37%
Payments to Acquire Property, Plant, and Equipment 24M USD 0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -1.46B USD -871%
Lessee, Operating Lease, Liability, to be Paid 164M USD 0%
Property, Plant and Equipment, Gross 1.84B USD +6.91%
Operating Lease, Liability, Current 32M USD +3.23%
Lessee, Operating Lease, Liability, to be Paid, Year Two 30M USD +7.14%
Lessee, Operating Lease, Liability, to be Paid, Year One 39M USD +8.33%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +25%
Deferred Income Tax Expense (Benefit) -80M USD -40.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 22M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 25M USD +13.6%
Deferred Tax Assets, Operating Loss Carryforwards 314M USD -4.56%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) -3M USD +85%
Current Income Tax Expense (Benefit) 116M USD +84.1%
Preferred Stock, Shares Authorized 1B shares 0%
Unrecognized Tax Benefits 31M USD +93.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 16M USD -5.88%
Operating Lease, Payments 35M USD +6.06%
Additional Paid in Capital 8.78B USD +0.38%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 2M USD +100%
Current Federal Tax Expense (Benefit) -8M USD -173%
Amortization of Intangible Assets 547M USD +4.19%
Depreciation, Depletion and Amortization 166M USD -4.05%
Deferred Tax Assets, Net of Valuation Allowance 452M USD -8.13%
Deferred State and Local Income Tax Expense (Benefit) -11M USD -1000%
Interest Expense 279M USD +10.3%